about
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachEpigenetic control of HIV-1 post integration latency: implications for therapyTargeting the Brain Reservoirs: Toward an HIV CureGold Nanocarriers for Macrophage-Targeted Therapy of Human Immunodeficiency Virus.HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases.Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a CureEradication of HIV-1 from the macrophage reservoir: an uncertain goal?Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophagesHuman Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.The feasibility of incorporating Vpx into lentiviral gene therapy vectors.Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive updateHuman Immunodeficiency Virus Infection and Host Defense in the Lungs.Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.Update and New Directions in Therapeutics for Neurological Complications of HIV Infections.Nanomedicines for dysfunctional macrophage-associated diseases.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin.HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection.UCLA1 aptamer inhibition of human immunodeficiency virus type 1 subtype C primary isolates in macrophages and selection of resistance.The role of polymorphonuclear neutrophils during HIV-1 infection.Wnt7a induces a unique phenotype of monocyte-derived macrophages with lower phagocytic capacity and differential expression of pro- and anti-inflammatory cytokines.Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.Macrophage Targeted Nanoparticles for Antiretroviral (ARV) Delivery.Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
P2860
Q26765937-F65CC586-6F94-44CE-94E6-A3535ECF0919Q26781191-E622A990-C2FC-40DD-A407-966B982078E2Q28075694-2BCABA46-DA72-46E4-B657-39583CEC25EAQ30394178-717CF141-117F-4E2C-BDD0-618FDD3BE90AQ33905696-053D6965-5489-40D5-9C22-A1CF85047DB1Q34664366-88ECF0C4-3C0D-4553-8699-F07D639BE833Q35447267-E80B834A-C598-4624-8C80-E0E9083FB073Q35544355-D9BEB7AF-A5E0-4BEB-935E-7D13C3C86E7DQ36299884-8F59853C-FE80-4597-BE8B-4FF518C137A6Q37102101-5F0402DF-B4A8-4A48-9B3F-6A4ED1793A0CQ37350713-95A22540-2AAA-4D1A-A6A4-270AD3E6EF4CQ37649116-3660BCCB-AE56-4431-BC83-7C8B4FDB4845Q38773755-268E250A-9F43-43D2-B302-335C80AB8FF5Q38787356-90F86D1C-2725-4FB6-901D-F980F849C8ABQ38887659-1DCCF3FE-6FFE-4DF6-BCFF-EE8D6FB48926Q39069052-7FAD149E-E904-4D3F-9EB7-7EBAAA5F0C3EQ39079514-2BBC11CF-F6DE-4309-B054-BA732169899FQ40125151-18B55B53-C3A5-478D-9D9A-0440019BC435Q40240401-E7299907-07B1-4C2E-9337-E738160E1832Q40889648-6EC5BEE1-B513-4545-8B97-D69FF0B00873Q41682866-F4F9AF9B-071B-43B6-8D53-7E101428F816Q41923884-AAD2DF6F-9A49-459B-ADA1-F46602EA0DE4Q48126684-19574291-2682-4203-AC0A-8B1FAD2E83B0Q50022535-305FC25D-A1C8-4EBF-8DF0-4A6AFA7D1B61Q50327669-0131C2F5-ECEB-47FC-919C-606EF611DCFEQ56777442-CAD55F89-727F-4727-A676-3CA37F1F8D26
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The macrophage: a therapeutic target in HIV-1 infection
@ast
The macrophage: a therapeutic target in HIV-1 infection
@en
The macrophage: a therapeutic target in HIV-1 infection
@nl
type
label
The macrophage: a therapeutic target in HIV-1 infection
@ast
The macrophage: a therapeutic target in HIV-1 infection
@en
The macrophage: a therapeutic target in HIV-1 infection
@nl
prefLabel
The macrophage: a therapeutic target in HIV-1 infection
@ast
The macrophage: a therapeutic target in HIV-1 infection
@en
The macrophage: a therapeutic target in HIV-1 infection
@nl
P2860
P3181
P356
P1476
The macrophage: a therapeutic target in HIV-1 infection
@en
P2093
Amit Kumar
Georges Herbein
P2860
P2888
P3181
P356
10.1186/2052-8426-2-10
P407
P577
2014-01-01T00:00:00Z
P5875
P6179
1052427265